As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time cost hundreds of thousands of dollars, for patients in their twilight years.
from Reuters: Health News https://reut.rs/2Gy9wIx
http://bit.ly/2zwRqiM
February 18, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on February 18, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.